News and Trends 11 Jun 2018 Scientists Warn CRISPR Therapy Could Cause Cancer as First Human Trials Take Place A study at Karolinska Institutet in Sweden has revealed that CRISPR-Cas9 gene editing could favor mutations in the most common cancer-causing gene. What does it mean for the first CRISPR therapy trials in humans? CRISPR-Cas9 has taken the life sciences field by storm, making gene editing simpler and faster than ever. Although CRISPR-Cas9 gene […] June 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jun 2018 Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder Saniona, a biotech focused on ion channel research, plans to test its lead candidate in a Phase IIa study for the rare eating disorder hypothalamic obesity. Saniona, based in Copenhagen, plans to start a Phase IIa trial testing its product, Tesomet, a combination of tesofensine and metoprolol, in hypothalamic obesity. The study would complement the […] June 11, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jun 2018 People with Innate Resistance to HIV Could Provide a Functional HIV Cure In the process of studying HIV-infected patients who naturally don’t need therapy to control the virus, scientists have found what could become a functional cure for HIV infections. A team of researchers from France, Italy, the UK and Australia has identified a molecule that could be transferred to HIV-positive people to help […] June 8, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 8 Jun 2018 The Textile Industry May Soon Turn to Insects to Help Produce Fabrics German researchers are exploring ways of using chitosan, which is derived from a component of insect skin called chitin, to replace toxic chemicals in the production of textiles. The researchers, who are based at the Fraunhofer Institute for Interfacial Engineering and Biotechnology in Stuttgart, plan to commercialize their technology and are already working with several […] June 8, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Startup Scout 8 Jun 2018 This Israeli Biotech Engineers Tobacco Plants to Make Collagen This week we’re in Ness Ziona, Israel, visiting CollPlant, a biotech that engineers tobacco plants to produce collagen for a variety of uses, including 3D printing and artificial tendons. Mission: CollPlant engineers tobacco plants to express five human genes, which enables the plants to produce recombinant human collagen. The material can be used in different […] June 8, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jun 2018 Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD UK biotech Microbiotica has entered into a multi-year collaboration with Genentech, one of the world’s first biotechs, to develop microbiome-based treatments for inflammatory bowel disease. Microbiotica, based in Cambridge, UK has entered into a collaboration with Genentech that could be worth up to €452M ($534M), a formidable amount in the microbiome space, with an undisclosed […] June 7, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2018 Best of European Biotech at ASCO 2018 Not able to attend the biggest cancer conference of the year? No problem. We have summarized what we think are the most interesting therapy developments presented by European biotech’s at ASCO this year. Once again, the cream of the cancer specialist crop gathered in Chicago to discuss and present the latest findings in cancer research at […] June 6, 2018 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2018 German DNA Treatment Reduces Ulcerative Colitis Symptoms Sterna Biologicals has obtained positive Phase IIa data for an ulcerative colitis treatment that uses DNA to inhibit inflammatory proteins, which could add to the diverse approaches being developed to treat inflammatory bowel disease. Sterna Biologicals, based in Marburg, Germany, has clinical data showing its ulcerative colitis treatment reduced the severity of the disease compared […] June 6, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jun 2018 British Researchers Regenerate Tooth Enamel With Biopolymers Researchers at Queen Mary University London have found a way to grow mineralized materials that can be used to regenerate hard tissue like dental enamel. British researchers have created a material that can be used as an artificial dental enamel to prevent and treat tooth decay or tooth sensitivity. To create the enamel, the scientists […] June 5, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jun 2018 French Biotech Raises €40M to Fight Hepatitis B and NASH Enyo Pharma has completed a Series B financing round to start Phase II trials by the end of this year testing its lead compound in two different forms of liver disease. Enyo Pharma, based in Lyon, has raised €40M from OrbiMed and other investors to start two Phase II trials testing its lead drug candidate […] June 5, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Expert Advice 5 Jun 2018 7 Life Science Marketing Trends That Blew Up in 2018 & How to Use Them Life science and pharmaceutical companies are notoriously cautious toward digital trends. Perhaps you have experienced this in your own company. You may have tried to push a marketing strategy that is almost old-hat in other industries by now, like email autoresponders, only to hear something along the lines of, “We’ve always done it how we’re […] June 5, 2018 - 15 minutesmins - By James Mathison Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jun 2018 British Company Gets a $100M Boost to Develop a Surgical Robotic Arm CMR Surgical has raised an impressive Series B round to develop a robotic arm to help during surgery that mirrors the movement of a human arm. CMR Surgical, based in Cambridge, UK, has raised $100M (€85M) in Series B funding to bring its surgical robot technology closer to a market launch in Europe and the US. […] June 4, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email